IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: analysis of factors contributing to benefit and risk in MAGELLAN
Cohen, A. T.1; Spiro, T. E.2; Buller, H. R.3; Haskell, L.4; Hu, D.5; Hull, R.6; Mebazaa, A.7; Merli, G.8; Schellong, S.9; Spyropoulos, A.; Tapson, V10
刊名JOURNAL OF THROMBOSIS AND HAEMOSTASIS
2011-07-01
suppl.2期:SI页:961-961
收录类别SCI
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Hematology ; Peripheral Vascular Disease
研究领域[WOS]Hematology ; Cardiovascular System & Cardiology
语种英语
WOS记录号WOS:000208992804384
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/59076
Collection北京大学第二临床医学院
作者单位1.Peking Univ, Peoples Hosp, Beijing, Peoples R China
2.Foothills Prov Gen Hosp, Calgary, AB, Canada
3.Lariboisiere Univ Hosp, Paris, France
4.Thomas Jefferson Med Ctr, Philadelphia, PA USA
5.Dresden Friedrichstadt Hosp, Dresden, Germany
6.Duke Univ, Med Ctr, Durham, NC 27706 USA
7.Kings Coll Hosp London, London SE5 8RX, England
8.Bayer HealthCare Pharmaceut Inc, Berkeley, CA USA
9.Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
10.Johnson & Johnson Pharmaceut Res & Dev LLC, San Diego, CA USA
Recommended Citation
GB/T 7714
Cohen, A. T.,Spiro, T. E.,Buller, H. R.,et al. Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: analysis of factors contributing to benefit and risk in MAGELLAN[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS,2011,suppl.2(SI):961-961.
APA Cohen, A. T..,Spiro, T. E..,Buller, H. R..,Haskell, L..,Hu, D..,...&Tapson, V.(2011).Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: analysis of factors contributing to benefit and risk in MAGELLAN.JOURNAL OF THROMBOSIS AND HAEMOSTASIS,suppl.2(SI),961-961.
MLA Cohen, A. T.,et al."Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism in acutely ill medical patients: analysis of factors contributing to benefit and risk in MAGELLAN".JOURNAL OF THROMBOSIS AND HAEMOSTASIS suppl.2.SI(2011):961-961.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Cohen, A. T.]'s Articles
[Spiro, T. E.]'s Articles
[Buller, H. R.]'s Articles
百度学术
百度学术Similar articles in
[Cohen, A. T.]'s Articles
[Spiro, T. E.]'s Articles
[Buller, H. R.]'s Articles
必应学术
必应学术Similar articles in
[Cohen, A. T.]'s Articles
[Spiro, T. E.]'s Articles
[Buller, H. R.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.